EFFECTS OF ABATACEPT ON MONOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：2
|
作者：
Bonelli, M. [1 ]
Ferner, E. [1 ]
Savitskaya, A. [1 ]
Blueml, S. [1 ]
Steiner, C-W [1 ]
Rath, E. [1 ]
Smolen, J. S. [1 ]
Scheinecker, C. [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2010年 / 69卷
关键词：
D O I：
10.1136/ard.2010.129668f
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A169
引用
收藏
页码：A67 / A67
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF ABATACEPT AND TNF INHIBITORS COMPARED WITH ULTRASONOGRAPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mamoto, K.
    Koike, T.
    Okano, T.
    Sugioka, Y.
    Tada, M.
    Inui, K.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 949 - 949
  • [2] Recommendations for the Use of Abatacept in Patients with rheumatoid Arthritis
    Gaubitz, M.
    Krueger, K.
    Haas, J. -P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (10): : 942 - 949
  • [3] Abatacept for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E134 - E134
  • [4] Abatacept for rheumatoid arthritis
    Rojahn, Ruth
    INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2011, 9 (04): : 456 - 457
  • [5] Abatacept for rheumatoid arthritis
    Maxwell, Lara
    Singh, Jasvinder A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [6] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Zhao, B. R.
    Chen, T.
    Zhang, J. T.
    Zhu, N.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1383 - 1384
  • [7] Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
    Bonelli, M.
    Ferner, E.
    Goeschl, L.
    Blueml, S.
    Hladik, A.
    Karonitsch, T.
    Kiener, H. P.
    Byrne, R.
    Niederreiter, B.
    Steiner, C. W.
    Rath, E.
    Bergmann, M.
    Smolen, J. S.
    Scheinecker, C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (03): : 599 - 607
  • [8] Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis
    Ryosuke Fukue
    Yuka Okazaki
    Takahisa Gono
    Masataka Kuwana
    Arthritis Research & Therapy, 24
  • [9] Abatacept downregulates Fcγ receptor I on circulating monocytes: a potential therapeutic mechanism in patients with rheumatoid arthritis
    Fukue, Ryosuke
    Okazaki, Yuka
    Gono, Takahisa
    Kuwana, Masataka
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [10] Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
    Mathieu, Sylvain
    Couderc, Marion
    Glace, Baptiste
    Pereira, Bruno
    Tournadre, Anne
    Dubost, Jean-Jacques
    Soubrier, Martin
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 259 - 264
12345